Ceros Capital Markets

GT Metabolic Solutions develops a minimally-invasive incision-less bypass technology for bariatric, metabolic, and digestive surgery.

DermaSensor, Inc. develops a hand-held device that uses artificial intelligence to evaluate skin lesions for cancer. It offers DermaSensor, a device that allows physicians and consumers to perform skin checks in physician offices and patient homes. The company’s device is also used for lesion identification, scanning, photon scattering, and algorithmic analysis. DermaSensor, Inc. was founded in 2009 and is based in Miami, Florida.

Pristine Surgical LLC, founded in 2011 and based in Manchester, New Hampshire, has developed a groundbreaking single-use digital imaging platform tailored for surgical and diagnostic rigid endoscopic procedures. The company specializes in single-use digital arthroscopes and laparoscopes that come in a completely sterile kit. By integrating high-definition digital imaging, advanced LED lighting, artificial intelligence, and cloud-based software, Pristine Surgical aims to enhance the efficiency and safety of over 23 million procedures annually. The platform not only improves the surgical experience for patients and healthcare providers but also addresses key concerns such as cost reduction, risk mitigation, and the elimination of cross-contamination associated with reprocessing instruments. Through its innovative technology, Pristine Surgical strives to streamline the entire surgical episode, ultimately improving communication and satisfaction among surgeons and healthcare facilities.

Pathology Watch Inc. is a company based in Salt Lake City, Utah, that specializes in remote specimen interpretation services for hospitals, laboratories, and dermatology centers through its digital pathology platform. Established in 2017, it collaborates with dermatopathologists and subspecialized pathologists to interpret digital slides, pathology reports, and biopsy samples. The company's telepathology services facilitate improved workflows for large clinics and hospitals, enhancing the efficiency of diagnosing skin cancer and other conditions. By digitizing the pathology workflow, Pathology Watch aims to elevate patient care quality, reduce operational costs, and create new revenue opportunities for healthcare providers. Its platform integrates seamlessly with existing electronic medical records, optimizing clinical decision-making and patient management.